CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

188.48 56.28 31.09 27.01
P/S ratio
0.24 0.25 0.22 0.32
P/FCF ratio
15.20 12.88 12.37 11.25
P/Operating CF
120.19 29.66 21.52 20.85
P/B ratio
1.31 1.33 1.18 1.66
EV/Sales
0.38 0.38 0.35 0.43
EV/EBITDA
9.86 10.31 8.78 9.70
EV/FCF
23.88 19.79 19.30 15.29
Current Ratio
0.83 0.84 0.87 0.87
Net Debt/EBITDA
14.95 16.56 8.85 8.14
Debt/Equity
0.90 0.86 0.81 0.77
Earnings Yield
0.53% 1.78% 3.22% 3.70%
Free Cash Flow Yield
6.58% 7.76% 8.09% 8.89%
Free Cash Flow per Share
0.08 2.06 2.67 4.42
Book value per Share
57.61 59.50 60.99 62.47
Free Cash Flow
98.00 2,606.00 3,400.00 5,654.00
EV/EBIT
30.57 33.16 23.92 21.69
Other line items

Show all line items

Columns are period end dates